|
Aerocrine: Positive reimbursement coverage continues for Aerocrine's asthma test
The Herald | HeraldOnline.com Specifically, FeNO testing is covered for the treatment of asthma when it is used in the diagnosis of allergic airway inflammation or when used in determining likelihood of steroid responsiveness in individuals with chronic symptoms suggestive of … |
View full post on asthma – Google News